ENTITY

Medtide (3880 HK)

6
Analysis
Health Care • China
Medtide is a China-based, peptide-focused contract research, development, and manufacturing organization (CRDMO). It offers full-cycle services from early-stage discovery, preclinical research, and clinical development to commercial-stage production of peptide new chemical entities (NCEs) and active pharmaceutical ingredients (APIs). The company was founded in 2020 and is headquartered in Hangzhou, China.
more
Company Event • 22 Apr 2027 16:00 • Upcoming
Add To Calendar

H2 2027

Company Event • 24 Sep 2026 16:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 23 Apr 2026 16:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 25 Sep 2025 16:00 • Upcoming
Add To Calendar

H1 2025

No more events
x